Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (34) Remove All (34) filter
  • News & Articles (17)
  • Research (6)
  • General (6)
  • Researcher Profiles (5)

Search found 34 items

All
Cancer immunotherapy drugs hold hope for some, but there’s still a way to go
Category: News & Articles
... fail. Who it works for now Nivolumab and pembrolizumab are checkpoint immunotherapy antibodies. They work by blocking barriers (or ... these drugs is with melanoma, which has long been known to respond to immunotherapy. In Australia, single or combination checkpoint immunotherapy  substantially helps about half of people with melanoma , ...
Inaugural International Cancer Immunotherapy Conference, New York, 16-19 September 2015
Category: Research
Funding is requested to attend the Inaugural International Cancer Immunotherapy Conference, September 16 -19, 2015, in New York, New York, ... sponsored by the Cancer Research Institute, Association for Cancer Immunotherapy, European Academy of Tumor Immunology and American ... and will bring together leaders in the fields of immunology and immunotherapy to disseminate and discuss recent research discoveries to ...
Improving the treatment benefit of immunotherapy in cancer
Category: General
Cancer immunotherapy is a therapeutic strategy that harnesses cancer patients ... target cancer cells. A new class of newly developed drugs in cancer immunotherapy (called immune checkpoint inhibitors) can cause long ... our understanding of important aspects of gene regulation involving immunotherapy checkpoint inhibitors. This project will increase our ...
Combining immunotherapy and targeted therapy in the treatment of human melanoma (Cancer Program Bridge Funding)
Category: Research
... is "targeting survival signalling pathways to sensitize melanoma to immunotherapy". Her research has drawn extensive attention from ... the melanoma field nationally and internationally. Research Combining immunotherapy and targeted therapy in the treatment of human melanoma ...
Researchers discover potential new melanoma treatment giving hope to patients
Category: News & Articles
... end stage melanoma whose cancers had become resistant to frontline immunotherapy treatment, a class of drugs known as Immune Checkpoint ... Azacitidine and Carboplatin could be effective in priming for anti-immunotherapy (Avelumab) in patients with advanced ICB-resistant ... repurposed chemo drugs in order to ‘prime’ them for a subsequent immunotherapy treatment. The patients survived an average of 47 weeks, ...
Cancer Public Seminar
Category: General
The HMRI National Science Week Cancer Public Seminar will explore immunotherapy and the future of cancer treatment. National Science Week Public Seminar: Immunotherapy and other drugs: A future of cancer treatment What does ... The HMRI National Science Week Cancer Public Seminar will explore immunotherapy and the future of cancer treatment Cancer Public Seminar | ...
Vanessa McGuigan HMRI Research Fellowship in Ovarian Cancer supported by the McGuigan Family
Category: General
... These cancers all respond exceptionally well to new drugs called immunotherapy that ‘take the breaks off’ the immune system and let ... also predict that the same patients will go on to respond well to immunotherapy. The HMRI Solution: HMRI researcher Dr Nikola Bowden is in the unique position of understanding the science of melanoma immunotherapy as well as ovarian drug therapy. She has a 5 year plan to ...
A novel approach to destruct melanoma
Category: General
... has spread beyond the original site. A new treatment approach called immunotherapy can cause  long-lasting melanoma  regression. However, only a small proportion of melanoma patients benefit from immunotherapy.   Resistance of melanoma to these treatments is closely ... protects melanoma cells from death induced by targeted therapy and immunotherapy drugs.  Understanding how theses cells evade death will ...
New MHF-funded Fellowship to fight brain cancer
Category: News & Articles
... dying from the disease every year. Dr Kim has developed a two-pronged immunotherapy treatment for HGG by enhancing a patient’s immunity and ... new immunotherapeutic platform that can overcome many hurdles of the immunotherapy against the brain tumour,’’ Dr Kim said. “My approach is highly targeted, cost-effective combinatorial immunotherapy and also has the potential to target the residual brain ...
Peanut allergy treatment is on the horizon – but don’t drop the EpiPen yet
Category: News & Articles
... Encouragingly, researchers have recently made progress in optimising immunotherapy, also called peanut “desensitisation”. In this process ... a study with 28 children in Durham, North Carolina, showed that oral immunotherapy could reduce allergic reactions to peanut. This study was ... Institute, Melbourne, studied an oral probiotic peanut combination immunotherapy in 62 allergic children without previous anaphylaxis. ...
  • 1
  • 2
  • 3
  • 4
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services